Louis
Pasteur
made
seminal
discoveries
in
microbiology,
immunology
and
vaccinology
that
transformed
clinical
science
saved
millions
of
lives.
Since
the
19th
century,
our
ability
to
study
infectious
disease
has
undergone
radical
changes
due
newly
emerging
technologies
infection
models.
In
this
Editorial,
I
consider
Pasteur's
impact
on
understand
combat
context
two
modern-day
pandemics:
coronavirus
2019
(COVID-19)
antimicrobial
resistance
(AMR).
During
COVID-19
pandemic,
we
witnessed
remarkable
ambition
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
innovate
effective
vaccines
prevent
disease.
For
comparatively
overlooked
pandemic
AMR,
require
same
level
urgency
develop
alternative
approaches
antibiotic-resistant
bacterial
strains
cause
deaths
annually.
statement
"chance
only
favours
mind
which
is
prepared"
a
principle
captures
'l'esprit
Pasteur'.
This
should
continue
guide
research
disease,
for
need
support
development
predictive
models
cutting-edge
mechanistic
prepare
us
discovery
therapeutic
impact.
Tissue Engineering Part A,
Journal Year:
2023,
Volume and Issue:
30(13-14), P. 377 - 386
Published: Dec. 8, 2023
Three-dimensional
(3D)
bioprinting,
a
promising
advancement
in
tissue
engineering
technology,
involves
the
robotic,
layer-by-layer
additive
biofabrication
of
functional
3D
and
organ
constructs.
This
process
utilizes
biomaterials,
typically
hydrogels
living
cells,
following
digital
models.
Traditional
uses
classic
triad
scaffolds,
physicochemical
signals
bioreactors.
A
scaffold
is
temporary,
often
biodegradable,
support
structure.
Tissue
primarily
falls
into
two
categories:
(i)
based
(ii)
free.
The
latter,
scaffold-free
gaining
increasing
popularity.
Organ
building
blocks
(OBB),
capable
self-assembly
self-organization,
such
as
spheroids,
organoids,
assembloids,
have
begun
to
be
utilized
bioprinting.
article
discusses
expanding
range
OBB,
presents
rapidly
evolving
collection
bioprinting
bioassembly
methods
using
these
finally,
outlines
advantages,
challenges,
future
perspectives
OBB
printing.
Developmental Biology,
Journal Year:
2022,
Volume and Issue:
494, P. 26 - 34
Published: Dec. 5, 2022
The
human
respiratory
system,
consisting
of
the
airway
and
alveoli,
is
one
most
complex
organs
directly
interfaced
with
external
environment.
diverse
epithelial
cells
lining
surface
are
usually
first
cell
barrier
that
comes
into
contact
pathogens
could
lead
to
deadly
pulmonary
disease.
There
an
urgent
need
understand
mechanisms
self-renewal
protection
these
against
harmful
pathogens,
such
as
SARS-CoV-2.
Traditional
models,
including
lines
mouse
have
extremely
limited
native
phenotypic
features.
Therefore,
in
recent
years,
mimic
complexity
lung,
alveoli
organoid
technology
has
been
developed
widely
applied.
TGF-β/BMP/SMAD,
FGF
Wnt/β-catenin
signaling
proven
play
a
key
role
lung
expansion
differentiation.
Thus,
we
summarize
current
novel
culture
strategies
discuss
their
application
for
understanding
biological
features
pathophysiology
diseases,
especially
COVID-19.
Lung
organoids
provide
excellent
vitro
model
research
platform.
ABSTRACT
As
early
as
in
the
acute
phase
of
coronavirus
disease
2019
(COVID-19)
pandemic,
research
community
voiced
concerns
about
long-term
implications
infection.
Severe
respiratory
syndrome
2
(SARS-CoV-2),
like
many
other
viruses,
can
trigger
chronic
disorders
that
last
months
or
even
years.
Long
COVID,
and
persistent
disorder
lasting
more
than
12
weeks
after
primary
infection
with
SARS-CoV-2,
involves
a
variable
number
neurological
manifestations,
ranging
from
mild
to
severe
fatal.
In
vitro
vivo
modeling
suggest
SARS-CoV-2
drives
changes
within
neurons,
glia
brain
vasculature.
this
Review,
we
summarize
current
understanding
neuropathology
long
particular
emphasis
on
knowledge
derived
organoid
models.
We
highlight
advantages
main
limitations
organoids,
leveraging
their
human-derived
origin,
similarity
cellular
tissue
architecture
human
tissues,
potential
decipher
pathophysiology
COVID.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 18 - 18
Published: Dec. 24, 2024
Respiratory
infections,
including
tuberculosis,
constitute
a
major
global
health
challenge.
Tuberculosis
(TB),
caused
by
Mycobacterium
tuberculosis
(Mtb),
remains
one
of
the
leading
causes
mortality
worldwide.
The
disease’s
complexity
is
attributed
to
Mtb’s
capacity
persist
in
latent
states,
evade
host
immune
defenses,
and
develop
resistance
antimicrobial
treatments,
posing
significant
challenges
for
diagnosis
therapy.
Traditional
models,
such
as
animal
studies
two-dimensional
(2D)
vitro
systems,
often
fail
accurately
recapitulate
human-specific
processes,
particularly
formation
granulomas—a
defining
feature
tubercular
infection.
These
limitations
underscore
need
more
physiologically
relevant
models
study
TB
pathogenesis.
Emerging
three-dimensional
(3D)
organoids
lung-on-chip
platforms,
offer
innovative
approaches
mimic
structural
functional
human
lung.
enable
recreation
key
aspects
granulomas,
cellular
interactions,
oxygen
gradients,
nutrient
limitations,
thereby
providing
deeper
insights
into
Mtb
This
review
aims
elucidate
advantages
3D
systems
bridging
translational
gap
between
traditional
experimental
clinical
applications.
Particular
emphasis
placed
on
their
potential
address
related
genetic
variability
both
pathogen,
advancing
research
therapeutic
development.
Louis
Pasteur
made
seminal
discoveries
in
microbiology,
immunology
and
vaccinology
that
transformed
clinical
science
saved
millions
of
lives.
Since
the
19th
century,
our
ability
to
study
infectious
disease
has
undergone
radical
changes
due
newly
emerging
technologies
infection
models.
In
this
Editorial,
I
consider
Pasteur's
impact
on
understand
combat
context
two
modern-day
pandemics:
coronavirus
2019
(COVID-19)
antimicrobial
resistance
(AMR).
During
COVID-19
pandemic,
we
witnessed
remarkable
ambition
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
innovate
effective
vaccines
prevent
disease.
For
comparatively
overlooked
pandemic
AMR,
require
same
level
urgency
develop
alternative
approaches
antibiotic-resistant
bacterial
strains
cause
deaths
annually.
statement
"chance
only
favours
mind
which
is
prepared"
a
principle
captures
'l'esprit
Pasteur'.
This
should
continue
guide
research
disease,
for
need
support
development
predictive
models
cutting-edge
mechanistic
prepare
us
discovery
therapeutic
impact.